Invest now in Preclinical Phase in novel drug molecule for the treatment of Melasma
ABOUT
Team
APPROACH
PIPELINE
ROADMAP
INVEST NOW
CONTACT
HUMAN MEDICINE
2017
MIC8411 (Melasma)
Dermatology
Small Molecule
Ask for Licensing
($3bn)
Screening
Hit to Lead
Lead optimization
Preclinical
IND
Clinical I,II,III